(WSVN) - The Federal Drug Administration has approved an expansion of a widely used diabetes drug.
The FDA’s new approval of Mounjaro, produced by Eli Lilly, applies to high-risk adults with Type 2 diabetes. Now it’s approved to help prevent heart attacks and strokes.
The pharmaceutical company said Mounjaro reduced major cardiovascular events by an extra 8% compared to its older diabetes drug, Trulicity.
Officials at Eli Lilly said researchers are now testing newer drugs that target even more hormones.
Copyright 2026 Sunbeam Television Corp. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.